TransMedics Group Inc.

TMDX | NASDAQ

Price Alert Chart Builder DCF Calculator

$88.47

+$1.18 (+1.35%)

Sep 22, 2026, 11:47 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $3.02B

Enterprise Value $3.41B

Beta 1.88

Average Volume 1.2M

Shares Outstanding (Diluted) 40.71M

Shares Change YoY 0.37%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US89377M1099

Price Performance

Price Change 1M -7.2%

Price Change 3M 18.2%

Price Change 6M -17.0%

Price Change YTD -28.9%

Price Change 1Y -30.3%

Price Change 3Y 57.6%

Price Change 5Y 178.3%

1M CAGR (ann.) 4.0%

1Y CAGR (ann.) -27.9%

5Y CAGR (ann.) 23.1%

All-Time CAGR 20.2%

Valuation

PE Ratio 22.61

Forward PE 33.03

PEG Ratio 0.18

Forward PEG 0.36

PS Ratio 4.51

Forward PS 3.40

PB Ratio 5.82

P/FCF Ratio 45.08

P/Adj. FCF Ratio 151.78

P/OCF Ratio 20.68

EV/Sales 5.10

EV/EBIT 36.38

EV/EBITDA 28.44

EV/FCF 50.99

Earnings Yield 4.4%

FCF Yield 2.2%

Adj. FCF Yield 0.7%

Financial Health

Net Debt $44.97M

Total Debt $867.72M

Cash & Short-Term Investments $472.68M

Total Assets $1.46B

Current Ratio 6.62

Quick Ratio 6.07

Debt / Equity Ratio 1.67

Debt / EBITDA 7.23

Debt / FCF 12.97

OCF / Debt 0.20

Interest Coverage 3.84

Altman Z-Score 2.79

Piotroski F-Score 4

Margins & Profitability

Gross Profit Margin 58.7%

Operating Profit Margin 12.2%

EBITDA Margin 17.9%

Net Profit Margin 22.7%

FCF Margin 10.0%

Adj. FCF Margin 3.0%

SBC / Revenue 5.5%

SBC Impact (per share) -70.3%

Returns

Return on Assets 10.4%

Return on Equity 33.0%

Return on Invested Capital 5.9%

Return on Capital Employed 6.0%

Return on Tangible Assets 10.4%

Historical Growth (CAGR)

Revenue CAGR 3Y 64.2%

Revenue CAGR 5Y 86.1%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 98.3%

EPS CAGR 5Y 192.9%

EPS CAGR 10Y N/A

FCF CAGR 3Y 357.1%

FCF CAGR 5Y 73.3%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 13

EPS Growth Next 3Y 7.0%

Revenue Growth Next 3Y 21.0%

Earnings Date Nov 3, 2026

EPS Estimate (next Q) $0.27

EPS Growth Est (next Q) -59.1%

Revenue Est (next Q) $177.03M

Revenue Growth Est (next Q) 23.1%

Fair Value Estimates

Graham Number $36.07

Graham Upside -58.7%

Lynch Fair Value $96.50

Lynch Upside 10.6%

Price Target $96.86

Price Target Upside 11.0%

Cash Flow

Operating Cash Flow $170.46M

Free Cash Flow $66.92M

Adj. Free Cash Flow $19.88M

FCF Per Share $2.29

OCF Per Share $4.22

OCF/S Ratio 21.8%

Income Statement

Revenue $668.47M

Gross Profit $392.35M

Operating Income $81.61M

EBITDA $119.98M

Net Income $151.7M

EPS (Diluted) $3.86

Revenue / Employee $744.4K

Profit / Employee $168.93K

Employees 898